AVEO PHARMACEUTICALS, INC. - FORM 10-Q - EX-32.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 906 - May 12, 2011

Attached files

file filename
10-Q - FORM 10-Q - AVEO PHARMACEUTICALS, INC.d10q.htm
EX-31.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 302 - AVEO PHARMACEUTICALS, INC.dex312.htm
EX-32.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 906 - AVEO PHARMACEUTICALS, INC.dex321.htm
EX-10.4 - SUBLEASE BETWEEN THE COMPANY AND ACCELERON PHARMA, INC. - AVEO PHARMACEUTICALS, INC.dex104.htm
EX-10.1 - EXTENSION LETTER AMENDMENT, DATED MARCH 30, 2011 - RON DEPINHO - AVEO PHARMACEUTICALS, INC.dex101.htm
EX-10.2 - EXTENSION LETTER AMENDMENT, DATED MARCH 30, 2011 - LYNDA CHIN - AVEO PHARMACEUTICALS, INC.dex102.htm
EX-31.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 302 - AVEO PHARMACEUTICALS, INC.dex311.htm
EX-10.3 - CONSULTING AGREEMENT, DATED JANUARY 1, 2010 - RAJU KUCHERLAPTI - AVEO PHARMACEUTICALS, INC.dex103.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of AVEO Pharmaceuticals, Inc. (the “Company”) for the fiscal quarter ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, David B. Johnston, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that, to his knowledge on the date hereof:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 12, 2011

 

/s/ David B. Johnston

David B. Johnston

Chief Financial Officer

AVEO PHARMACEUTICALS, INC. Reports